Researchers Are Testing Paxlovid as a Treatment for Long COVID
Long COVID currently affects millions of people in the U.S. Symptoms can include brain fog, tremors, sleep disorders, and shortness of breath. The National Institutes of Health (NIH) and other academic medical centers recently launched clinical trials aimed at finding treatments for long COVID. Researchers think that there may be different causes of long COVID symptoms in different people, which is why they are conducting different clinical trials in many centers around the country.Source: Verywell Health
For Hurricane Katrina Survivors, COVID-19 Brings a New Mental Health Toll
A new study shows that for some low-income mothers in New Orleans, the COVID-19 pandemic was associated with the same, or worse, mental health impacts as Hurricane Katrina, one of the worst national disasters in U.S. history.
Participant-centric Trial Will Test if Antiviral Paxlovid Can Help With Long COVID
Researchers are still in the dark on the mechanisms underlying and how to treat long COVID. A new clinical trial using the oral antiviral Paxlovid will provide urgently needed insights for COVID long-haulers and their providers.
How Africa can close the gap in COVID-19 vaccine equity: One student’s perspective
A new commentary authored by Yale School of Public Health PhD student Natasha Turyasingura, in collaboration with senior researchers from Yale and Columbia University, suggests ways Africa can improve COVID-19 vaccination rates and prepare for future pandemics.
Experts: Pfizer tests on COVID vaccines, treatment in line with industry standards
An Associated Press review of a claim that Pfizer acknowledged in a statement that it conducted “gain of function” research as part of its development of a vaccine and a separate medical treatment for COVID-19 found the claim is false.Source: Associated Press
How the global Pandemic Fund can live up to its great potential
World leaders in November launched a new global Pandemic Fund housed at the World Bank to break the historic pattern of “panic and neglect” regarding global disease outbreaks. The fund was crafted with good intentions and has enormous potential. But that’s far from sufficient to guarantee success.Source: The Washington Post